Celsunax Den Europæiske Union - dansk - EMA (European Medicines Agency)

celsunax

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. hos voksne patienter, til at hjælpe med at differentiere sandsynligt, demens med lewy organer fra alzheimers sygdom.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Nutryelt koncentrat til infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nutryelt koncentrat til infusionsvæske, opløsning

laboratoire aguettant - chromchloride, vandfri, ferrogluconat, kaliumiodid, kobbergluconat, mangangluconat, natriumfluorid, natriummolybdat, natriumselenit, zinkgluconat - koncentrat til infusionsvæske, opløsning